Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Extended-release oxycodone[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 13
2OXYCODO----[1] 6
3Oxycodone[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[5] 6, 13, 70, 226, 298
4Oxycodone Depot ”Sandoz”, depot tablets[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298
5OXYCODONE HYDROCHLORIDE[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298
6Oxycodone naloxone prolonged release tablets[2] Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
7Oxycodone Orion[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70
8Oxycodone/naloxone prolonged release t[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
9Oxycodone/Naloxone Prolonged Release tablets[2] Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
10Oxycodone/naloxone prolonged release tablets 10 mg /5 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
11Oxycodone/naloxone prolonged release tablets 10/5 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
12Oxycodone/naloxone prolonged release tablets 20 mg /10 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
13Oxycodone/naloxone prolonged release tablets 20/10 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
14Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
15Oxycodone/naloxone prolonged release tablets 5/2.5 mg[3] Manganese citrate,
Naloxone,
Oxycodone		[2] D05312 (Name: Oxycodone),
D08249 		[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
16Oxycodonhydrochlorid ”Lannacher”, depot tablets----[1] 298
17PR Oxycodone[1] Oxycodone[1] D05312 (Name: Oxycodone)[3] OPRD1,
OPRK1,
OPRM1 💬		[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6